Cargando…

Pulmonary hypertension associated with neurofibromatosis type 1

Neurofibromatosis type 1 (NF1), also known as von Recklinghausen disease, is a frequent autosomal dominant genetic disorder with a prevalence of 1 in 3000. Pulmonary hypertension (PH) associated with NF1 (PH-NF1) is a rare but severe complication of NF1 and is classified as Group 5 PH, defined as “P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jutant, Etienne-Marie, Girerd, Barbara, Jaïs, Xavier, Savale, Laurent, O'Connell, Caroline, Perros, Frederic, Sitbon, Olivier, Humbert, Marc, Montani, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2018
Materias:	Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488681/ https://www.ncbi.nlm.nih.gov/pubmed/30158278 http://dx.doi.org/10.1183/16000617.0053-2018

Ejemplares similares

Acute decompensated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2017)

Sex and gender in pulmonary arterial hypertension
por: Cheron, Céline, et al.
Publicado: (2021)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Weatherald, Jason, et al.
Publicado: (2021)

A rare case of sarcoidosis-associated pulmonary hypertension in a patient exposed to silica
por: Bourlier, Delphine, et al.
Publicado: (2016)

Pulmonary capillary haemangiomatosis: a distinct entity?
por: Weatherald, Jason, et al.
Publicado: (2020)

Pulmonary hypertension associated with busulfan
por: Hagenburg, Jean, et al.
Publicado: (2021)

Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)

Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers
por: Boucly, Athénaïs, et al.
Publicado: (2022)

Pulmonary Hypertension Complicating Fibrosing Mediastinitis
por: Seferian, Andrei, et al.
Publicado: (2015)

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era
por: Savale, Laurent, et al.
Publicado: (2018)

Reply to Jin et al. and to Sun et al.
por: Boucly, Athénaïs, et al.
Publicado: (2021)

An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants
por: Montani, David, et al.
Publicado: (2022)

External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry
por: Boucly, Athénaïs, et al.
Publicado: (2022)

Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation
por: Montani, David, et al.
Publicado: (2021)

Hypoxemia during sleep and overnight rostral fluid shift in pulmonary arterial hypertension: a pilot study
por: Jutant, Etienne-Marie, et al.
Publicado: (2021)

French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Brenot, Philippe, et al.
Publicado: (2019)

New trends in pulmonary hypertension
por: Cullivan, Sarah, et al.
Publicado: (2023)

The isobaric pulmonary arterial compliance in pulmonary hypertension
por: Chemla, Denis, et al.
Publicado: (2021)

Heritable pulmonary hypertension: from bench to bedside
por: Girerd, Barbara, et al.
Publicado: (2017)

Exertional dyspnoea in pulmonary arterial hypertension
por: Dumitrescu, Daniel, et al.
Publicado: (2017)

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
por: Launay, David, et al.
Publicado: (2018)

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension
por: Girerd, Barbara, et al.
Publicado: (2010)

Factors predicting outcome after pulmonary endarterectomy
por: Tromeur, Cécile, et al.
Publicado: (2018)

COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study
por: Montani, David, et al.
Publicado: (2022)

Pulmonary hypertension associated with diazoxide: the SUR1 paradox
por: Montani, David, et al.
Publicado: (2023)

Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?
por: Le Pennec, Romain, et al.
Publicado: (2022)

Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension
por: Hoeper, Marius M., et al.
Publicado: (2019)

Chronic thromboembolic pulmonary hypertension
por: Kim, Nick H., et al.
Publicado: (2019)

Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension
por: Le Ribeuz, Hélène, et al.
Publicado: (2020)

Non-Invasive Determination of Cardiac Output in Pre-Capillary Pulmonary Hypertension
por: Lador, Frédéric, et al.
Publicado: (2015)

Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation
por: Beurnier, Antoine, et al.
Publicado: (2020)

Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension
por: Hautefort, Aurélie, et al.
Publicado: (2017)

Respiratory symptoms and radiological findings in post-acute COVID-19 syndrome
por: Jutant, Etienne-Marie, et al.
Publicado: (2022)

Clinical trial design and new therapies for pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2019)

Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy
por: Montani, David, et al.
Publicado: (2014)

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission
por: Jevnikar, Mitja, et al.
Publicado: (2021)

Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension
por: Perros, Frédéric, et al.
Publicado: (2021)

Haemodynamic definitions and updated clinical classification of pulmonary hypertension
por: Simonneau, Gérald, et al.
Publicado: (2019)

Iron deficiency in pulmonary arterial hypertension: perspectives
por: Quatredeniers, Marceau, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d2j4pqfmm274lffvl3h63hpg4c